Actively Recruiting
Supportive Care Study Using PATHWAYS Coaching Sessions and Educational Guides for Adults with Locally Advanced Rectal Cancer
Led by Massachusetts General Hospital · Updated on 2025-05-18
80
Participants Needed
2
Research Sites
27 weeks
Total Duration
AI-Summary
What this Trial Is About
Researchers are evaluating the feasibility and acceptability of a psychoeducational intervention called PATHWAYS compared to enhanced usual care for patients with locally advanced rectal cancer starting neoadjuvant multimodality treatment. The study is designed as a randomized controlled trial to explore how well this intervention supports patient self-efficacy in managing treatment challenges and maintaining quality of life. The study has two phases Phase I tested the initial PATHWAYS intervention with 20 participants, while Phase II is a pilot randomized trial with about 60 participants, assessing a refined PATHWAYS program. Participants in the PATHWAYS group receive four coaching sessions, a patient education guidebook, and a coaching workbook. Those in the enhanced usual care group receive an information resource guide tailored to patients with locally advanced rectal cancer. Participants will be assessed for how many remain in the intervention over four weeks and their acceptance of the intervention by 12 weeks. The trial includes enrollment tracking and measures acceptability of the intervention. Participants will engage in coaching sessions and complete study procedures in English or with interpreter help, with ongoing monitoring of retention and feedback throughout the study period.
CONDITIONS
Brief Title
An Informational and Supportive Care Intervention for Patients With Locally Advanced Rectal Cancer
Research Team
K
Kelsey Lau-Min, MD, MSCE
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
